Literature DB >> 10407834

[Anhedonia--a general nosology surmounting correlate of a dysfunctional dopaminergic reward system?].

A Heinz1.   

Abstract

The dopaminergic reward system is activated by primary rewarding factors such as food, sexual activity and parental care. Its activation enhances the occurrence of behaviors which induced the stimulation of dopaminergic neurotransmission. Indications of a dysfunction of the dopaminergic reward system are found in major depression, schizophrenia, and addictive disorders. It has been hypothesized that dysfunction of the dopaminergic reward system is associated with anhedonia, the inability to experience pleasure. However, animal studies indicate that a reduction of central dopaminergic neurotransmission is associated with a decrease in incentive salience of reward-indicating stimuli and not with anhedonia per se. Sensitization of dopaminergic neurotransmission, on the other hand, seems to induce cue-dependent craving in addicted patients. In schizophrenia, phasic, stimulus-dependent dopamine release in the striatum may play a role in the abnormal attribution of salience to previously neutral stimuli.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407834     DOI: 10.1007/s001150050454

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  13 in total

Review 1.  [Neuroimaging in substance abuse disorders].

Authors:  A de Mendelssohn; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2004-07       Impact factor: 1.214

Review 2.  [Antidepressant effects of dopamine agonists. Experimental and clinical findings].

Authors:  M R Lemke
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

Review 3.  [New insights into the pathogenesis and pathophysiology of depression].

Authors:  C Schüle; T C Baghai; R Rupprecht
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

Review 4.  How antipsychotics work-from receptors to reality.

Authors:  Shitij Kapur; Ofer Agid; Romina Mizrahi; Ming Li
Journal:  NeuroRx       Date:  2006-01

Review 5.  [Syndromal versus nosological diagnosis].

Authors:  M Jäger; K Frasch; T Becker
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

Review 6.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

Review 7.  [Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment].

Authors:  M Hornyak; H Benes; I Eisensehr; J Haan; J Kassubek; I Peglau; K Stiasny-Kolster; C Trenkwalder
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

8.  Alterations of monetary reward and punishment processing in chronic cannabis users: an FMRI study.

Authors:  Björn Enzi; Silke Lissek; Marc-Andreas Edel; Martin Tegenthoff; Volkmar Nicolas; Norbert Scherbaum; Georg Juckel; Patrik Roser
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Prevalent hallucinations during medical internships: phantom vibration and ringing syndromes.

Authors:  Yu-Hsuan Lin; Sheng-Hsuan Lin; Peng Li; Wei-Lieh Huang; Ching-Yen Chen
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

10.  Serotonin, inhibition, and negative mood.

Authors:  Peter Dayan; Quentin J M Huys
Journal:  PLoS Comput Biol       Date:  2008-02       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.